Company intelligence / Profile preview

Pro-ficiency

Raleigh, North Carolina, United Statessimulations-plus.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Pro-ficiency provides simulation-based training, compliance monitoring tools, real-time data & predictive analytics for the life sciences sector. Their technology improves protocol adherence in clinical trials by reducing deviations among investigators. The company was acquired by Simulations Plus in June 2024 for $100 million cash. No direct clinical results as they do not run therapeutic programs.

Modalities: Non-pharmacological therapy (simulation-based training and analytics)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

QHP Capital-backed prior to acquisition by Simulations PlusClients include approximately forty pharma/biotech companies as of mid–2024

Beyond the preview

Go deeper on Pro-ficiency.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-ficiency.

Explore the full profile